[Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000517:prevention & control*; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D006348:Cardiac Surgical Procedures; D005112:Extracorporeal Circulation; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006355:Heart-Lung Machine; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D011479:Protamines / Q000494:pharmacology; D013916:Thrombelastography
D000933:Antifibrinolytic Agents; D011479:Protamines; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin
Das Verhalten on Blutgerinnung und Fibrinolyse im Venenblut nach prophylaktischer Anwendung von Antifibrinolytika bei Herzoperationen mit Hilfe des extrakorporalen Kreislaufs.